HOME >> MEDICINE >> NEWS
Novel drug-antidote strategy provides greater control of drug action

e Clinical Research Institute. "We can't easily stop or reverse the action of these drugs quickly. If this new approach works out, it should give us much greater control in so many situations where a drug is long-lasting but has potential side effects."

The researchers took the challenge, and decided to create a drug-antidote pair from scratch. Their target was human coagulation factor IXa, a pivotal clotting factor in the complex cascade of biochemical events that ultimately leads to the formation of a blood clot. Past studies have shown an association between elevated levels of factor IXa and the onset of acute coronary syndrome.

The researchers discovered anticoagulant aptamers that target factor IXa. Aptamers are single-stranded nucleic acids (RNA or DNA) that bind to specific protein targets with high affinity and specificity. The first drug from this new class of therapeutics, Eyetech's Macugen, recently demonstrated high efficacy for the treatment of age-related macular degeneration in Phase III clinical trials.

"As soon as the drug is developed, the antidote comes relatively easily," Sullenger said. "Once we determined the identity of our drug, we were able to design an antidote that would bind to the drug at a specific site, causing a conformational change, which rapidly and durably neutralizes the activity of the drug."

The Duke researchers previously described the discovery and design of this anti-factor IXa aptamer-antidote pair and demonstrated the blood-thinning activity of the drug and the neutralization activity of the antidote in the test tube in a paper published in Nature (Sept. 5, 2002).

In their current experiments, the researchers first demonstrated that the factor IXa inhibitor was an effective anticoagulant in pigs. Then, once the blood was anticoagulated, they injected the antidote into the treated pigs.

"The antidote neutralized more than 95 percent
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
17-Oct-2004


Page: 1 2 3 4

Related medicine news :

1. Novel therapy tested in mice could chase away cat allergies
2. Novel antibiotic shows promise in shortening treatment duration of tuberculosis
3. Novel p53 gene-based therapy boosts immune system and reduces tumor size
4. Novel drugs help solve Gleevec resistance
5. Novel imaging technique shows abnormal brain anatomy in children with ADHD
6. Novel imaging technique shows lymph nodes, metastases in breast cancer without surgery
7. Novel delivery method for nutrients wins Kaye Innovation Award for Hebrew university students
8. Novel vitamin discovery offers clues for cancer chemotherapy and lipid disorders
9. Novel findings about neovessel formation
10. Novel MRI technique provides clear images of blood flow
11. Novelty-seeking teens may be more easily influenced by tobacco advertisements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2019)... ... 09, 2019 , ... WEDI , the nation’s leading nonprofit authority on ... a trusted advisor to the U.S. Department of Health and Human Services (HHS), announced ... of Officers* as well as the re-election of ten previous board members to serve ...
(Date:12/9/2019)... ... December 09, 2019 , ... Cocoa Beach is preparing ... one of the world’s most-dazzling Santa-themed gatherings. , What began as a simple family ... slightly zany – holiday tradition. Now, ten years in, there’s no better place for ...
(Date:12/8/2019)... ... December 08, 2019 , ... ... has announced the Top 52 Best Homeland Security Degree Programs for 2020. The ... universities in the nation. Each program is evaluated based on curriculum quality, graduation ...
(Date:12/6/2019)... ... December 06, 2019 , ... In a ceremony where ... Salt Lake Community College’s (SLCC) Emergency Medical Technician (EMT) Program—Maria Mazzel Delgado, ... the AT&T Public Safety Hero Scholarship to support their first responder training. ...
(Date:12/6/2019)... (PRWEB) , ... December 06, 2019 , ... ... symposium for healthcare professionals in Baltimore, Maryland at the AES Annual Meeting. The ... learning objectives: , 1. Understand methods of quantitative sEMG analysis during ictal events;, ...
Breaking Medicine News(10 mins):
(Date:12/9/2019)... ... December 09, 2019 , ... ... their work in improving workforce performance with a Brandon Hall Technology Excellence ... Excellence Awards recognize the best organizations that have successfully deployed tools and ...
(Date:12/8/2019)... (PRWEB) , ... December 07, 2019 , ... ... years to have over 700 weekly ongoing face-to-face mutual support groups in 32 ... nicotine addiction. , Nicotine Anonymous members also provide several daily phone and internet ...
(Date:12/6/2019)... ... 2019 , ... Nobilis Therapeutics , a clinical stage ... today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational ... Phase 2b trial for the treatment of patients with Posttraumatic Stress Disorder (PTSD). ...
Breaking Medicine Technology:
Cached News: